Researcher

Dr Tristan Reekie

Fields of Research (FoR)

Organic chemistry, Medicinal and biomolecular chemistry, Optical properties of materials

SEO tags

Expanding Knowledge in the Chemical Sciences

Biography

I completed my PhD in 2013 at ANU and then completed a postdoctoral position at ETH Zurich before returning to Australia to work at the University of Sydney. I began my independent career at ANU in 2019, which I have now continued at the University of New South Wales Canberra.

My research is focused on small molecule organic chemistry with application to materials, plant science and medicinal chemistry.

In addition to my research, I am also...view more

I completed my PhD in 2013 at ANU and then completed a postdoctoral position at ETH Zurich before returning to Australia to work at the University of Sydney. I began my independent career at ANU in 2019, which I have now continued at the University of New South Wales Canberra.

My research is focused on small molecule organic chemistry with application to materials, plant science and medicinal chemistry.

In addition to my research, I am also heavily involved in teaching and outreach to enhance interest in science amongst students and the general public. I have long-term involvement with programs such as the Australian Chemistry Olympiad to encourage the next generation of scientist.

My Qualifications

PhD ANU 2013

B. Sci (Hons) ANU 2007

LLB ANU 2010

My Awards

The Peter Andrews Award for Innovation in Medicinal Chemistry/Chemical Biology (2022)

Young Tall Poppy Science Award (2020) for promoting science among students, teachers and an appreciation of science in the broader community.

My Research Activities

My research uses organic synthesis techniques to create molecules for application in medicinal chemistry, materials and plant sciences. I have a strong focus on both commercialisation and publishing results in peer-reviewed journals. It is the latter area where I have made the significant impact, generating new compounds to treat substance use disorders and social disfunction. The success of this research has led to the establishment of a spin-out company, Kinoxis Therapeutics, where I continue to work as their Head of Chemistry alongside my academic role.